![](/img/cover-not-exists.png)
Quality-of-life and performance status results from the phase 3 RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma
Al-Batran, S.-E., Van Cutsem, E., Cheul Oh, S., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O.N., Kim, T.-Y., Cunningham, D., Rougier, P., Muro, K., Liepa, A.M., Chandrawansa, K., EmLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv625
Date:
January, 2016
File:
PDF, 574 KB
english, 2016